Medium-throughput hydrate screening using the Crystal 16

Anand Sistla1, Yi Wu, Penney Khamphavong

  • 1Research Enabling Group, Pfizer Global Research and Development, La Jolla Laboratories, San Diego, California 92121, USA. Anand.Sistla@Pfizer.com

Summary

Early identification of compound hydrate formation is crucial in drug development. A new screening method using Crystal 16™ efficiently predicts hydrate propensity, aiding compound selection and process control.

Related Concept Videos